Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split
Ernexa Therapeutics Inc. CAMBRIDGE, Mass., April 30, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today anno…